Viread Prescribing Information
Download Full U.S. Prescribing Information, including BOXED WARNINGS
Adobe Acrobat Reader
Downloading files on this page requires the Adobe Acrobat Reader
|
|
Viread® (tenofovir disoproxil fumarate)
| Study Number |
Study Title |
Study Summary |
| GS-02-1008 |
A phase II, open-label, multicentre, randomised, comparator study of substitution with tenofovir or abacavir in HIV-1
infected individuals, with a viral load < 50 copies/mL, receiving a thymidine analogue (zidovudine or stavudine) as part of their highly active antiretroviral therapy (HAART) |
Download Study Summary |
| GS-02-1015 |
"3 O D & opiate substitution" Open-label multicenter study to assess the efficacy, the tolerability and the adherence of an once daily (QD) taken antiretroviral therapy (ART) containing the NtRTI tenofovir DF 300 mg in combination with the best suitable once a day regimen being 1 NRTI plus 1 PI or 1 NRTI plus 1 NNRTI in HIV-1-infected IVDU-patients with opiate substitution being either antiretroviral-naïve or with suppressed viral load and without a history of virological failure |
Download Study Summary |
| GS-02-1016 |
Randomized multicenter open-label, pilot trial to evaluate the efficacy and safety of switching HIV-1 stable infected patients under HAART to a new once daily triple therapy combination including EFV+3TC+TDF versus a dual QD therapy containing EFV+TDF
|
Download Study Summary |
| GS-99-903E |
A Phase 3, Randomized, Double-Blind, Multicenter Study of the Treatment of Antiretroviral-Naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination with Lamivudine and Efavirenz Versus Stavudine, Lamivudine, and Efavirenz |
Download Study Summary |
| GS-104-0235 |
A Phase 4, Single-Arm Study To Evaluate the Safety, Antiretroviral Activity and Pharmacokinetics of Tenofovir Disoproxil Fumarate in Combination with Emtricitabine in HIV-1 Infected Patients Experiencing Various Degrees of Renal Impairment |
Download Study Summary |
| GS-US-174-0102 |
A Randomized, Double-Blind, Controlled Evaluation of Tenofovir DF versus Adefovir Dipivoxil for the Treatment of Presumed Pre-core Mutant Chronic Hepatitis B |
Download Study Summary |
| GS-US-174-0103 |
A Randomized, Double-Blind, Controlled Evaluation of Tenofovir DF versus Adefovir Dipivoxil for the Treatment of HBeAg Positive Chronic Hepatitis B
|
Download Study Summary |
| GS-US-104-0318 |
A Phase IV, Randomized, Double-Blind, Placebo-Controlled Two-Phase Crossover Study of the Metabolic Impact of Tenofovir Disoproxil Fumarate on HIV-1 Seronegative Healthy Adult Males |
Download Study Summary |
|
